Tech Transfer Roundup: Boehringer Teams Up With A*STAR On Targeted Oncology R&D

 
• By Joseph Haas

National Resilience, Parker Institute team to incubate cancer startups. Metropolitan AntiViral Drug Accelerator will focus on eight molecular features of SARS-CoV-2 to create novel oral antivirals.

Tech Transfer
• Source: Shutterstock

More from Deals

More from Business